Cargando…
Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
The hepatocyte growth factor (HGF)/c-met axis plays a crucial role in cancer development by promoting cellular proliferation, motility, and morphogenesis, as well as angiogenesis. Different cellular distributions of both the ligand and the receptor in benign vs malignant lesions indicate this biolog...
Autores principales: | Trovato, Maria, Campennì, Alfredo, Giovinazzo, Salvatore, Siracusa, Massimiliano, Ruggeri, Rosaria Maddalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391983/ https://www.ncbi.nlm.nih.gov/pubmed/28469401 http://dx.doi.org/10.1177/1177271917701126 |
Ejemplares similares
-
Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic
por: Ruggeri, Rosaria Maddalena, et al.
Publicado: (2020) -
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
por: Campennì, Alfredo, et al.
Publicado: (2022) -
What is New on Thyroid Cancer Biomarkers
por: Ruggeri, Rosaria M., et al.
Publicado: (2008) -
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto's thyroiditis
por: Trovato, Maria, et al.
Publicado: (2017) -
Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma
por: Bouattour, Mohamed, et al.
Publicado: (2018)